Top Markets
#1 Tutorial Tutorial +48.51%
#2 Unit Pump Unit Pump +24.64%
#3 Pump.fun Pump.fun +24.64%
#4 Siacoin Siacoin +24.49%
#5 Official Trump Official Trump +23.94%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +22.43%
#7 EXOD EXOD +18.93%
#8 MowCat MowCat +18.13%
#9 Stacks Stacks +18.09%
#10 LayerZero LayerZero +17.67%
Coin of the day
Tutorial Tutorial
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Energenesis Biomedical CO.,LTD. Energenesis Biomedical CO.,LTD.

Energenesis Biomedical CO.,LTD.

6657
Classement en actions #22642
Energenesis Biomedical CO.,LTD., a firm established in 2012 and headquartered... Energenesis Biomedical CO.,LTD., a firm established in 2012 and headquartered in Taipei, Taiwan, is an active participant in the biomedicine sector. The company specializes in the development of a diverse range of medical solutions and research materials. Its primary pharmaceutical pipeline includes ENERGI-F703, which is currently undergoing Phase II clinical trials for the treatment of diabetic foot ulcers, and ENERGI-F701, a topical solution for addressing alopecia that is also in its second phase of clinical assessment. The comprehensive portfolio of therapeutic agents further encompasses: ENERGI-F711, formulated as a cream for burns. ENERGI-F702, designed to combat metabolic diseases. ENERGI-F704, targeting inflammatory bowel disease. ENERGI-F708, for the management of asthma. ENERGI-F705, aimed at controlling Parkinson's disease. ENERGI-F707, addressing mitochondrial deficiencies. ENERGI-F706, used to treat cachexia. ENERGI-F709, which serves as a vaccine adjuvant. ENERGI-F710, intended for the regulation of blood phosphate levels. Beyond its therapeutic developments, Energenesis Biomedical also provides a selection of scientific research products, including reagents for Western blotting, cell culture supplements, components for protein isolation and quantification, various laboratory dyes, and buffer solutions.
Prix de l'action
$0.97305026
Dernière synchronisation: 2026-08-21
Capitalisation boursière
$85.54M
Changement (1 jour)
1.16%
Changement (1 an)
-50.40%
Pays
TW
Échange Energenesis Biomedical CO.,LTD. (6657)

Catégorie

Healthcare
Bénéfices pour Energenesis Biomedical CO.,LTD. (6657)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de Energenesis Biomedical CO.,LTD., les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Energenesis Biomedical CO.,LTD. de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH